125742 S2 M1 com195lkz carton kzoo

Pfizer Documents (PHMPT/FDA)

Pfizer Bla Submission

Pfizer 16 Plus Documents

1

Document text

NO COPY
NO COPY
NO COPYNO COPY
XXXXXX
MM/YYYYGS1 Data
Matrix
(GTIN,
Lot, Exp)XXXXXXMM/YYYYGS1 Data
Matrix
(GTIN,
Lot, Exp)NOTE:
Area around QR Code is a requiredquiet zone.
Nothing is to print within this space.Code to scan as:
https://www.pfi.sr/comirnaty
LOT:
EXP:
LOT:
EXP:195 Multiple Dose Vials
(after dilution each vial contains 6 doses of 0.3 mL)Suspension for Intramuscular Injection195 Multiple Dose Vials
(after dilution each vial contains 
6 doses of 0.3 mL)Suspension for Intramuscular Injection
STORAGE: Prior to dilution, store at 
-90°C to -60°C (-130°F to -76°F).Store in this carton to protect from light.
DOSAGE AND ADMINISTRATION: After
dilution, each vial contains 6 doses of 0.3 mL.See prescribing information or scan QR code.
MUST BE DILUTED BEFORE USE with sterile
0.9% Sodium Chloride Injection, USP (supplied separately).
After dilution, store the vaccine at 2°C to 25°C (35°F to 77°F). 
Discard after 6 hours.
Contains no preservative.
STORAGE: Prior to dilution, store at -90°C to -60°C
(-130°F to -76°F). Store in this carton to protect from light.
DOSAGE AND ADMINISTRATION:
After dilution, each vial contains 6 doses of 0.3 mL.See prescribing information or scan QR code.Rx onlyNDC 0069-1000-02
300691000021
COM195LKZ
COM195LKZManufactured for
BioNTechManufacturing GmbHAn der Goldgrube 1255131 Mainz, Germany
Manufactured by
Pfizer Inc.New York, NY 10017
US License No. XXXX
MUST BE DILUTED BEFORE 
USE with sterile 0.9% Sodium Chloride Injection, USP (supplied separately).After dilution, store the vaccine at 2°C to 25°C (35°F to 77°F). 
Discard after 6 hours.
Contains no preservative.B O TE H F Z RB NT C PF ER ON E HP ZE B O T CH F Z R I NT C PF ER ON E HP ZE B O T CH F Z RComirnaty Carton Label - Kzoo COM195LKZ     16P      April 23, 2021     am
Black      PMS 7671      PMS 2162      PMS 7597
Minimum point size - 5pt.
FPO UPC-A
FPOComirnaty Carton Label COM195LKZ - Kzoo_16.pdf   1   4/23/21   1:34 PM
090177e196fd281d\Approved\Approved On: 10-May-2021 03:35 (GMT)
FDA-CBER-2021-5683-0225024